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Implication for health policy/practice/research/medical education:
Apigenin and luteolin, two active ingredients of Dracocephalum kotschyi extract, are responsible for its antispasmodic activity 
and might be used for this purpose in patients having abdominal spasm.
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Introduction: Aerial parts of Dracocephalum kotschyi have been used as antispasmodic agents 
in Iranian traditional medicine. Recent pharmacological studies confirmed antispasmodic 
activity of D. kotschyi extract. The objective of this research was to investigate antispasmodic 
activities of apigenin and luteolin to find out if they are responsible for the spasmolytic activity 
of hydroalcoholic extract of D. kotschyi.
Methods: Aerial parts of D. kotschyi were extracted with ethanol. Antispasmodic effect of 
hydroalcoholic extract of D. kotschyi, apigenin and luteolin were examined on KCl and/or 
acetylcholine (ACh)-induced contractions in rat isolated ileum. 
Results: Hydroalcoholic extract of D. kotschyi concentrations-dependently inhibited KCl and 
ACh induced contractions with IC50 values of 41 ± 10 µg/mL and 133 ± 19 μg/mL, respectively. 
Apigenin concentrations-dependently inhibited KCl and ACh induced contractions with 
IC50 values of 57 ± 12 μM and 80 ± 18 µM, respectively. Luteolin concentrations-dependently 
inhibited KCl induced contractions with IC50 values of 68 ± 14 μM. Loperamide reduced both 
KCl and ACh induced contraction with IC50 values of 189 ± 44 nM and 82 ± 20 μM, respectively. 
Conclusion: In this study apigenin and luteolin were identified as two active ingredients 
responsible for antispasmodic activities of D. kotschyi extract.
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Introduction
Dracocephalum kotschyi (Labiatae family) is an endemic 
herbaceous plant of Iran (1-3). Dracocephalum genus 
plants are used in traditional medicine as carminative 
and tonic and treatment of ailment such as congestion, 
headache, stomachache and liver diseases (1-4). Recent 
pharmacological studies have confirmed some medicinal 
properties of D. kotschyi including antihyperlipidemic 
(5), immunomodulatory (6), anti-inflammatory (7) and 
anticancer (8) effects. 
In traditional herbal books there are substantial reports 
about use of D. Kotschyi as antispasmodic herbal medicine 
(9). Recent pharmacological studies have supported 
the antispasmodic effects of D. Kotschyi extract in both 
isolated ileum and rat uterus smooth muscles (10,11). 
The D. kotschyi extract inhibited the response to KCl, 
acetylcholine and electrical field stimulations in rat 
isolated ileum (10). In addition, it has been reported that 
hydroalcoholic extract of D. kotschyi possesses relaxant 
effect on uterus responses to KCl, acetylcholine and 
electrical nerve stimulation as well as oxytocin-induced 
contractions (11). Above findings confirms that D. 
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kotschyi extract possesses components with antispasmodic 
activities on smooth muscle of ileum and uterus.
Furthermore, hydroalcoholic and hexane extracts of D. 
kotschyi attenuated the intestinal charcoal meal transit, 
confirming the antispasmodic action in vivo (12). 
The hydroalcoholic and hexane extracts of D. kotschyi 
also significantly inhibited the castor oil and MgSO4-
induced diarrhea in mice which could be related to its 
antispasmodic activity (12). In a separate experiment, the 
anti-inflammatory effect of hydroalcoholic extract of D. 
kotschyi was examined on acetic acid-induced colitis in 
rats and it was found to be very effective (13). From these 
experiments, it can be concluded that D. kotschyi extract 
possesses potent antispasmodic activities both in vitro and 
in vivo and could be used as a remedy for the treatment of 
gastrointestinal disorders especially those associated with 
intestinal spasm. Therefore, identification of the activity 
of plants constituents is necessary for drug development. 
Dracocephalum kotschyi is an aromatic medicinal plant 
enrich in essential oils (5,14), valuable flavonoids (15), 
monoterpene glycosides and trypanocidal terpenoids (16). 
Some of the constituents of the D. kotschyi extract have 
already been published (15). These include calycopterin, 
xanthomicrol, isokaempferide, luteolin, apigenin, luteolin 
7-O-beta-D-glucopyranoside, lutcolin 3’-O-beta-D-
glucuronide, apigenin 4’-O-beta-D-glucopyranoside, 
acacetin 7-O-beta-D-glucopyranoside and rosmarinic 
acid (15). However, so far there is no report about the 
antispasmodic activity of these components. Therefore, in 
this research we have investigated antispasmodic effects of 
apigenin and luteolin and compared with antispasmodic 
action of hydroalcoholic extract of D. kotschyi and 
loperamide. 
Materials and Methods
Plant materials
Aerial parts of D. kotschyi Boiss. (Labiatae family) 
were collected in June 2015 from Chadegan (in Isfahan 
province-Iran) and identified at the Botany Department 
of the Faculty of Sciences, University of Isfahan. A 
voucher specimen of the plant (No. 1519) deposited in the 
herbarium of the Faculty of Pharmacy and Pharmaceutical 
Sciences, Isfahan University of Medical Sciences. The 
plant materials were dried in shadow and grained to 
powder using electrical miller (Moulinex, France). The 
dried plant material was used for extraction by maceration 
(17). Powdered plant material was thoroughly mixed with 
70% ethanol and left for two hours. Wetted plant materials 
were packed into percolator and soaked in 70% ethanol 
for three days, with occasional shaking. Plant extract was 
evacuated from bottom tap passing through cotton cloth 
placed on the bottom of the percolator. This procedure 
was repeated three times and the combined filtrate was 
evaporated using rotary evaporator (Buchi Rotavapor 
RE) at 50°C to get the final hydroalcoholic extract of D. 
kotschyi. After evaporating the ethanol, amount of dried 
crude extract was determined (w/w). 
Antispasmodic assessment
Experiments were conducted on adult male Wistar 
rats (180-220 g) bred in School of Pharmacy, animal 
house. All animals were handled in compliance with the 
principles of the guide for care and use of laboratory 
animal care approved by the university committee (18). 
On the day of experiment, a rat was killed by a blow on 
the head, followed by exsanguinations. A portion of 
ileum was removed and placed in oxygenated Tyrode’s 
solution at room temperature. A section of ileum (2-3 cm) 
was mounted for isotonic contraction under 1 g tension 
in 20 mL organ bath (Harvard, England) containing 
Tyrode’s solution and continuously gassed with O2 at 
37°C. Ileum contraction was measured using a Harvard 
isotonic transducer and recorded on a Harvard Universal 
Oscillograph (England) pen recorder device. Initially the 
oscillograph was calibrating, and 3 successive washes 
were given and the tissue was allowed to relax to a stable 
baseline. When the tissue baseline was established, KCl 
(80 mM) was added in to the organ bath in order to induce 
a sustained tonic contraction. The inhibitory effect of D. 
kotschyi extract or drugs were examined on isolated rat 
ileum contraction induced by KCl. Fifteen minutes after 
addition of KCl, extract or drugs were added to the bath at 
5 minutes intervals in a cumulative manner using two-fold 
increments in concentration, until maximum inhibition 
was obtained. In the case of acetylcholine (ACh), non-
cumulative manner was used. ACh was added into the 
tissue bath to give the final bath concentration of 5 µg/
mL. ACh was allowed to act for 30 seconds before it was 
washed with fresh Tyrode’s solution. The time-matched 
control tissues were treated with an equivalent volume of 
the vehicle. 
Drugs and solutions
Solidified extract was weighted and prepared as 20 mg/
mL stock solution in dimethyl sulfoxide (DMSO). 
Further dilutions were made in distilled water. Apigenin 
and luteolin (Sigma, China) were made up in DMSO as 
10mM stock solutions. Loperamide was dissolved in 
DMSO as 20 mM stock solution. KCl was prepared as 2M 
stock solution. Acetylcholine (Sigma) was prepared in 
distilled water as 1mM stock solution. Tyrode’s solution 
(NaCl, 136.9; KCl, 2.68; CaCl2, 1.8; MgCl2, 1.05; NaHCO3, 
11.9; NaH2PO4, 0.42 and glucose 5.55 mM) was prepared 
in distilled water. Unless stated, all the chemicals were 
purchased from Merck (Germany).
Data analysis
The tissue contractile responses were measured as 
maximum amplitude from pretreatment baseline and 
expressed as the percentage of the initial contraction 
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induced by KCl or ACh. All values were quoted as mean 
± standard error of the mean (SEM). The IC50 value 
(Drug concentration causing 50% of maximum inhibitory 
response) was calculated for each tissue and mean and 
SEM was determined for each group of results. SigmaPlot 
computer program was used for statistical analysis and 
plotting the graphs. The IC50 values were used as an index 
for comparison of antispasmodic activities.
Results
Dried hydroalcoholic extract of D. kotschyi had dark 
greenish color. A sample of concentrated extract was 
thoroughly dried on a hot pate and the yield of dried 
extract was calculated to be 23% (w/w). 
Antispasmodic studies 
Rat isolated ileum suspended in Tyrode’s solution 
gradually relaxed to a stable baseline over 15-30 min. KCl 
(80 mM) caused a tonic contraction which maintained 
for the duration of the study. Acetylcholine (ACh, 5 µM) 
caused a rapid phasic contraction in rat ileum during 30 
seconds of contact time. KCl and ACh concentrations 
were chosen to produce maximum contractile responses 
in the tissue. 
Antispasmodic activities of apigenin and luteolin were 
examined on isolated ileum contraction for comparison 
with the total extract of hydroalcoholic extract of D. 
kotschyi by constructing full concentration-response 
curve. Loperamide, an opioid agent with antimotility 
action, was used as a positive standard drug in this 
research. As expected, loperamide concentration-
dependently inhibited rat ileum contractile responses 
induced by both KCl and ACh with IC50 values of 189±44 
nM and 82 ± 20 µM respectively (Figure 1). 
Hydroalcoholic extract of D. kotschyi, concentration-
dependently inhibited both KCl and ACh induced 
contraction in the rat ileum. The inhibitory effect on 
KCl response was seen with bath concentration of 8 µg/
mL and complete inhibition was achieved with extract 
concentration of 256 µg/ml (Figure 2). Inhibitory effect 
of D. kotschyi extract on ACh response started with 
bath concentration of 64 µg/mL and total inhibition was 
Figure 1. Inhibitory concentration-responses curves for loperamide 
on contractions induced by KCl and acetylcholine (ACh) in rat isolated 
ileum. 
Ordinate scales: spasm remaining as a % of the contraction prior to 
drugs addition. Abscissa scales: log10 concentration of loperamide. 
Each point is mean of six experiments and the vertical lines show the 
SEM (n=6).
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Figure 2. Inhibitory concentration response curves for hydroalcoholic 
extract obtained from D. kotschyi on tonic contractions induced in rat 
isolated ileum by KCl (80mM). 
Ordinate scales: spasm remaining as a % of the contraction prior to 
drugs addition. Abscissa scales: log10 concentration of extract. Each 
point is mean of six experiments and the vertical lines show the SEM 
(n=6). The control groups were treated with equivolume amount of 
vehicle (DMSO). The stars show the statistically significant difference 
with corresponding point in the time-matched control groups. *P < 
0.05, ***P < 0.001 (Student’s t-test).
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Figure 3. Inhibitory concentration responses curve for hydroalcoholic 
extract of D. Kotschyi on phasic contractions induced in rat isolated 
ileum by acetylcholine (5 µM). Ordinate scales: spasm remaining as a 
% of the contraction prior to addition of extract. Abscissa scales: log10 
concentration of extract. Each point is mean of six experiments and 
the vertical lines show the SEM (n=6). The control groups were treated 
with equivolume amount of vehicle (DMSO). Gradual increase in tissue 
responses in the control group is statistically significant (ANOVA, 
P < 0.05). The stars show the statistically significant difference with 
corresponding point in the time-matched control groups. *P < 0.05, 
***P < 0.001 (Student’s t test).
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seen with 512 µg/mL extract in the bath (Figure 3). The 
inhibitory concentrations causing 50% of maximum 
response (IC50 value) were 41 ± 10 µg/mL and 133 ± 19 µg/
mL for KCl and ACh respectively. 
Apigenin, a known component of D. kotschyi, also in a 
concentration-dependent manner inhibited KCl, as well as 
ACh induced contractions with IC50 values of 57 ± 12 μM 
and 80 ± 18 µM respectively. First sign of attenuation of 
KCl response was seen with 8 µM apigenin in the bath and 
at bath concentration of 480 µM, apigenin totally removed 
the KCl response in the rat ileum (Figure 4). Inhibitory 
effect of apigenin on ACh response was seen with similar 
concentration ranges (Figure 5). Luteolin, another 
component of D. kotschyi extract, in a concentration-
dependent manner inhibited KCl induced contraction in 
rat ileum with IC50 value of 80 ± 18 μM (Figure 5). Initial 
reduction was observed with bath concentration of 14 μM 
and at bath concentration of 450 μg/mL, luteolin wiped out 
the tonic contraction induce by KCl (Figure 6). Potencies 
of apigenin, luteolin and loperamide are compared in 
Table 1. In the vehicle treated control groups, equivalent 
volume of DMSO not only did not reduce ACh response 
but also was observed a gradual increase in contractile 
response (Figures 3 and 5). Low concentration of DMSO 
had no effect on KCl response (Figure 2). 
Discussion
Dracocephalum kotschyi hydroalcoholic extract is a 
relaxant of ileum and uterus smooth muscles and 
possessed antispasmodic and antidiarrheal activities (10-
12). However, D. kotschyi extract contains a mixture of 
Figure 4. Inhibitory concentration-responses curve of apigenin on the 
tonic contraction induced by KCl in rat isolated ileum. 
Ordinate scales: spasm remaining as a % of the contraction prior to 
apigenin addition. Abscissa scales: log10 concentration of apigenin. 
Each point is mean of six experiments and the vertical lines show the 
SEM (n=6). The control groups were treated with equivolume amount 
of vehicle (DMSO). There are not statistically significant changes in 
the fluctuation seen in the vehicle treated control group (ANOVA). The 
stars show the statistically significant differences of the test tissues 
with the corresponding points in the time-matched control groups. 
*P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t test).
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Figure 5. Inhibitory concentration responses curve for apigenin on 
phasic contraction induced in rat isolated ileum by acetylcholine (5 
µM). 
Ordinate scales: spasm remaining as a % of the contraction prior to 
apigenin addition. Abscissa scales: log10 concentration of apigenin. 
Each point is mean of six experiments and the vertical lines show the 
SEM (n=6). The control groups were treated with equivolume amount 
of vehicle (DMSO). Gradual increase in tissue response in the control 
group is statistically significant (ANOVA, P < 0.05). The stars show the 
statistically significant difference with corresponding point in the time-
matched control groups. **P < 0.01, ***P < 0.001 (Student’s t test).
Figure 6. Inhibitory concentration responses curve of luteolin in rat 
isolated ileum for the tonic contraction induced by KCl (80 mM). 
Ordinate scales: spasm remaining as a % of the contraction prior to 
luteolin addition. Abscissa scales: log10 concentration of luteolin. Each 
point is mean of six experiments and the vertical lines show the SEM 
(n=6). The control groups were treated with equivolume amount of 
vehicle (DMSO). Observed fluctuation in the vehicle treated control 
group response was not statistically significant (ANOVA). The stars 
show the statistically significant differences of the test tissues with the 
corresponding points in the time-matched control groups. *P < 0.05, 
**P < 0.01, ***P < 0.001 (Students t test). 
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several active substances with various pharmacological 
properties including, anti-inflammatory, anti-cancer, anti-
dyslipidimea, etc (5-8). Therefore, it is essential to identify 
the active substances which could be responsible for 
antispasmodic activities on smooth muscle. Preparation 
of standard drug form purified compound is more 
convenient and administrations of unwanted substances 
are avoided. Although several constituents of D. kotschyi 
extract are known (15), however, the main problem is 
that we had no idea which chemical components were 
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responsible for the antispasmodic activities. Apigenin 
and luteolin are two flavonoids that have been identified 
in the hydroalcoholic extract D. kotschyi (15). Therefore, 
antispasmodic activities of apigenin and luteolin were 
examined on isolated ileum contractions. 
In this study loperamide was used as a standard drug and as 
expected it reduced ileum contraction in a concentration-
dependent manner. Loperamide is an opioid agent with 
antimotility action which inhibits peristalsis and slows 
gastrointestinal motility by the effect on circular and 
longitudinal muscle of the intestine (19,20). Loperamide 
act by several different mechanisms, mediated by various 
opioid receptors on the enteric nerves and smooth muscles 
(19,20). 
This study revealed that apigenin and luteolin as well 
as hydroalcoholic extract of D. kotschyi have direct 
relaxant effects on rat ileum smooth contractions by KCl 
and ACh. ACh is cholinergic neurotransmitter which 
acts on muscarinic M3-receptors on smooth muscle 
of ileum. Muscarinic receptors are G-protein couple 
receptors (GPCR) and cause the release of Ca2+ ions 
from intracellular stores via increasing phospholipase-C 
activities and generation of inositol triphosphate 
(21,22). Addition of high potassium concentration 
(80 mM KCl) into extracellular solution results in cell 
membrane depolarization and activation of voltage-gated 
calcium channels (23). Increase in intracellular Ca2+ ion 
concentrations results in smooth muscle contraction 
(23). However, other studies have shown that membrane 
depolarization induced by high concentrations of 
extracellular KCl can also cause Ca2+ sensitization in 
many smooth muscles (23). In the case of KCl induced 
tonic contraction it has been proposed that tonic force 
maintenance in the smooth muscle is dependent on rhoA 
kinase activity (23). However, some isotype of protein 
kinase C (PKC) may also play a role in causing KCl-
induced sensitization (24). Flavonoids such an apigenin 
and luteolin are reported to inhibit PKC activities (25-
27). Inhibition of PKC by apigenin and luteolin indicates 
that both apigenin and luteolin are acting intracellulary 
and this is consistent with inhibition of both ACh and 
KCl induced contractions. In addition, luteolin is a non-
selective competitive inhibitor of phosphodiesterases (28) 
which could also play a role in its antispasmodic activity. 
Therefore, apigenin and luteolin are two active ingredients 
of D. kotschyi extract with potent antispasmodic activities. 
Table 1. Comparison of potency of loperamide, apigenin and luteolin 
for inhibiting KCl (80 mM) and acetylcholine (ACh, 5 µM) responses 
in rat isolated ileum
pD2 values
Loperamide Apigenin Luteolin
KCl 6.72 4.24 4.10
ACh 4.09 4.10 -
Potency has expressed as pD2 value (log10 potency in molar 
concentration).
Comparison of inhibitory concentration at molar 
concentration showed that potencies of apigenin and 
luteolin were close to that of loperamide especially for 
inhibiting acetylcholine response (Table 1). However, D. 
kotschyi extract is a mixture of several substances and 
comparison of potency in molar concentration was not 
feasible. Nevertheless, as luteolin and apigenin are found 
to be relatively potent antispasmodic agents, it can be 
concluded that they are responsible for antispasmodic 
activity of D. kotschyi extract, although, contribution of 
other components could not be excluded. 
Drugs that reduce spasm in the gut are of great value 
in gastrointestinal disorders including irritable bowel 
syndrome and diverticular disease (29). It has been 
shown that apigenin as well as D. kotschyi extract reduce 
the intestinal transit and has anti-diarrheal activity 
in mice (12). Therefore, apigenin has been shown to 
have antispasmodic activities both in vitro and in vivo. 
Furthermore, apigenin has anti-inflammatory activities 
in acetic acid-induced colitis (13). These findings confirm 
that apigenin is a suitable candidate for the treatment of 
irritable bowel syndrome in which intestinal spasms and 
diarrhea are part of the clinical signs.
Conclusion
In this research relaxant effects of apigenin and luteolin 
were examined on rat ileum and it was found to have 
direct relaxation actions on gastrointestinal smooth 
muscle. Apigenin and luteolin not only inhibited 
contraction induced by ACh but they also were as much 
potent as loperamide. Therefore, it can be concluded that 
apigenin and luteolin are two components responsible for 
antispasmodic activity of D. kotschyi extract. However, 
D. kotschyi extract is enriched in bioactive substances. 
Therefore, further pharmacological researches for 
identification of other active components with 
antispasmodic activities are recommended.
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